Comparative Effectiveness of Targeted Therapies in BRAF Positive Metastatic Melanoma in the US

NCT05260684 · clinicaltrials.gov ↗

COMPLETED

Status

716

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Encorafenib
DRUG: Binimetinib
DRUG: Vemurafenib
DRUG: Cobimetinib
DRUG: Dabrafenib
DRUG: Trametinib

Sponsor

Pfizer